BCL2 and diffuse large B-cell lymphoma: These results mirror those identified in a cohort of 50 pediatric patients with DLBCL derived from the German Berlin-Frankfurt-Munster multicenter trial by Oschlies et al. in which no BCL2 rearrangements were identified [29].